Report Scope & Overview:
Orthobiologics Market size was valued at USD 8.56 billion in 2022 and is expected to reach USD 13.20 billion By 2030 and grow at a CAGR of 5.6% over the forecast period of 2023-2030.
The market for medical goods and procedures that use biological materials to encourage the healing and regeneration of musculoskeletal tissues, including bones, cartilage, tendons, and ligaments, is known as the orthopaedics industry. The goal of orthobiologics, a branch of regenerative medicine, is to speed up the body's natural healing processes by utilising biological elements like cells, growth factors, and biomaterials. Various medical procedures, such as orthopaedic operations, sports medicine, and trauma care, can make use of orthobiologics. They may be superior to conventional therapies in terms of speedier healing, decreased discomfort, and better functional outcomes.
Allografts (donor’s bone), autografts (patient's own bone), and artificial substitutes are all examples of bone transplants. They help with fracture healing or fusion treatments and increase bone development. Proliferation factors are naturally occurring proteins that aid in tissue regeneration and cell proliferation. Examples include recombinant human bone morphogenetic proteins (rhBMPs) and platelet-rich plasma (PRP).
Undifferentiated cells called stem cells have the capacity to differentiate into multiple cell types. The potential of mesenchymal stem cells (MSCs) to develop into bone, cartilage, and other tissues makes them a popular choice in orthobiologics. A number of variables, including an ageing population, an increase in the prevalence of orthopaedic disorders, developments in biotechnology, and a move towards minimally invasive procedures, have contributed to the tremendous rise of the orthobiologics market in recent years. Orthobiologic products are developed and marketed by a number of major market participants, including pharmaceutical, biotechnology, and medical device companies.
Effective orthopaedic remedies are still needed as the population ages and stays active.
Sports injuries and active lifestyles are growing.
Sports-related injuries are more common now that more people are participating in active lives and sports. Orthobiologic therapies, such as PRP injections and stem cell therapy, are utilised to hasten the healing and recovery of these wounds, which is propelling market expansion.
Orthobiologic procedures can be costly, especially when using cutting-edge technology or cell-based therapy.
Moral and legal issues to consider.
The use of some orthobiologic products presents moral and legal questions, especially those that contain stem cells or human tissue. To safeguard patient safety and preserve public trust, regulatory bodies and healthcare practitioners must make sure that the source and usage of these products adhere to moral standards and laws.
Orthobiologics are largely employed in the treatment of orthopaedic problems like ligament injuries, osteoarthritis, and fractures.
Initiatives for Collaborative Research.
The field of orthobiologics can benefit from collaboration between academic institutions, research organisations, and business stakeholders. Collaboration efforts can hasten the development of novel orthobiologic medicines, strengthen clinical evidence, and enhance manufacturing procedures.
Due to their complex manufacturing processes and high cost of research and development, orthobiologic treatments can be pricey.
Insufficient clinical evidence.
Despite the potential of orthobiologic therapies, there is frequently a dearth of high-calibre clinical data to support their long-term efficacy and safety. Due to the complexity of these treatments, the requirement for standardised protocols, and the time and resources necessary for thorough studies, conducting large-scale, well-designed clinical trials with long-term follow-up can be difficult.
Impact of Covid-19:
The epidemic made clear the necessity for better healthcare systems and cutting-edge therapeutic choices. By taking advantage of the possibilities of regenerative medicine and personalised medicines, the orthobiologics market can profit from this increased attention to healthcare. As healthcare systems place a higher priority on the creation of durable and creative solutions, the demand for orthobiologic products that assist in tissue repair, healing, and regeneration could rise.
The unusual public health issue known as the COVID-19 epidemic has had a significant impact on the global market for Orth biologics. The Consumer Product Safety Commission (CPSC) in the United States revealed that during the first seven months of COVID-19, there were a total of outbreaks, and visits to emergency departments for consumer product-related accidents decreased by 20-25%. The largest decrease in injuries was seen in track and field-related sports injuries. Basketball, baseball, football, hockey, and other sports saw about 55-60% less activity from March through September 2020. The CPSC claims that these huge declines are a result of the pandemic-related suspension of youth and school sports leagues in the spring and summer of 2020.
Impact of Russia and Ukraine-War:
Foreign investments may decrease in the impacted regions as a result of the war and ongoing geopolitical tensions. Reduced funding may affect attempts at innovation, research and development, and the growth of orthobiologic product manufacturing facilities. The market's expansion and growth in the area may be constrained as a result.
The war and its aftermath may disrupt infrastructure and healthcare in affected areas. Patients' ability to get ortho-biologic therapy may be limited by harm to medical facilities, personnel relocation, and population relocation. Access to healthcare facilities and resources may have a substantial impact on the demand for orthobiologic products. Depending on the unique circumstances and how the issue is resolved, the influence on the orthopaedics market's size and length may change. Market dynamics and growth potential are significantly shaped by the geopolitical environment and regional stability.
By Product Type:
Bone Morphogenetic Protein
Demineralized Bone Matrix
Synthetic Bone Substitutes
Soft tissue injuries
Osteoarthritis and degenerative arthritis
Maxillofacial & Dental applications
By End User:
Research and academic institutions
Hospitals and ambulatory centres
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of the Middle East & Africa
Rest of Latin America
The orthobiologics market is dominated by North America. The area boasts a developed healthcare system, cutting-edge research facilities, and a high incidence of orthopaedic diseases. Due to its extensive patient population, favourable reimbursement practices, and ongoing research and development efforts, the United States currently holds a dominant position in the North American market. With the expanding use of orthobiologic therapies and rising healthcare spending, Canada also contributes to the market's expansion.
The Asia-Pacific region is witnessing strong expansion in the orthobiologics market due to factors such as a huge population base, increasing healthcare expenditure, and expanding awareness about sophisticated treatment alternatives.
Countries like China, India, Japan, and South Korea are important contributors to market growth in the area.
Increasing disposable incomes, increasing healthcare infrastructure, and a growing prevalence of orthopaedic disorders boost the market for orthobiologic products in the Asia-Pacific region.
The major key players are Medtronic PLC, Exactech Inc., Synthes Inc., Stryker Corporation, Zimmer Biomet, Smith & Nephew PLC, Tornier Inc., DePuy Synthes Inc., RTI Surgical Inc., Bioventus LLC and other players are listed in the final reports.
Exactech Inc: On 26th April 2023, The NewtonTM knee balancing technology from Exactech, a developer and manufacturer of cutting-edge implants, instrumentation, and smart technologies for joint replacement surgery, demonstrated its capacity to perform dynamic joint balance with a minimal learning curve in a new study published in the Journal of Arthroplasty. For knee surgeons who are looking for a full-range soft tissue management system that offers personalised patient data in real-time without requiring a corresponding capital commitment, this research holds a lot of promise.
|Market Size in 2022||US$ 8.56 Bn|
|Market Size by 2030||US$ 13.20 Bn|
|CAGR||CAGR of 5.6% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product Type (Bone Morphogenetic Protein, Allograft, Demineralized Bone Matrix, Viscosupplementation Products, Synthetic Bone Substitutes)
• By Application (Soft tissue injuries, spinal fusion, osteoarthritis and degenerative arthritis, fracture healing, maxillofacial and dental applications)
• By End User (Research and academic institutions, hospitals and ambulatory centres, and dental clinics)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Medtronic PLC, Exactech Inc., Synthes Inc., Stryker Corporation, Zimmer Biomet, Smith & Nephew PLC, Tornier Inc., DePuy Synthes Inc., RTI Surgical Inc., Bioventus LLC|
|Key Drivers||• Effective orthopaedic remedies are still needed as the population ages and stays active.
• Sports injuries and active lifestyles are growing.
|Market Opportunities||• Orthobiologics are largely employed in the treatment of orthopaedic problems like ligament injuries, osteoarthritis, and fractures.
• Initiatives for Collaborative Research.
Ans: The Orthobiologics Market is to grow at 5.6% Over the Forecast Period 2023-2030.
Ans: The Orthobiologics Market is to Hit USD 12.92 Billion By 2030.
Ans: Medtronic PLC, Exactech Inc., Synthes Inc., Stryker Corporation, Zimmer Biomet, Smith & Nephew PLC, Tornier Inc., DePuy Synthes Inc., RTI Surgical Inc., Bioventus LLC.
Ans: The Orthobiologics Market size was valued at USD 8.56 Billion in 2022.
Ans: The stem cells that heal the wound after a bone fracture either produce new bone or new cartilage.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Russia and Ukraine War
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Orthobiologics Market Segmentation, By Product Type
8.1 Bone Morphogenetic Protein
8.2 Allograft, Demineralized Bone Matrix
8.3 Viscosupplementation Products
8.4 Synthetic Bone Substitutes
9. Orthobiologics Market Segmentation, By Application
9.1 Soft tissue injuries
9.2 Spinal fusion
9.3 Osteoarthritis and degenerative arthritis
9.4 Fracture healing
9.5 Maxillofacial and dental applications
10. Orthobiologics Market Segmentation By End User
10.1 Research and academic institutions
10.2 Hospitals and ambulatory centres
10.3 Dental clinics
11. Regional Analysis
11.2 North America
11.2.1 North America Orthobiologics Market By Country
11.2.2North America Orthobiologics Market By Product Type
11.2.3 North America Orthobiologics Market By Application
11.2.4 North America Orthobiologics Market By End User
22.214.171.124 USA Orthobiologics Market By Product Type
126.96.36.199 USA Orthobiologics Market By Application
188.8.131.52 USA Orthobiologics Market By End User
184.108.40.206 Canada Orthobiologics Market By Product Type
220.127.116.11 Canada Orthobiologics Market By Application
18.104.22.168 Canada Orthobiologics Market By End User
22.214.171.124 Mexico Orthobiologics Market By Product Type
126.96.36.199 Mexico Orthobiologics Market By Application
188.8.131.52 Mexico Orthobiologics Market By End User
11.3.1 Europe Orthobiologics Market By Country
184.108.40.206 Europe Orthobiologics Market By Product Type
11.3.3 Europe Orthobiologics Market By Application
11.3.4 Europe Orthobiologics Market By End User
220.127.116.11 Germany Orthobiologics Market By Product Type
18.104.22.168 Germany Orthobiologics Market By Application
22.214.171.124 Germany Orthobiologics Market By End User
126.96.36.199 UK Orthobiologics Market By Product Type
188.8.131.52 UK Orthobiologics Market By Application
184.108.40.206 UK Orthobiologics Market By End User
220.127.116.11 France Orthobiologics Market By Product Type
18.104.22.168 France Orthobiologics Market By Application
22.214.171.124 France Orthobiologics Market By End User
126.96.36.199 Italy Orthobiologics Market By Product Type
188.8.131.52 Italy Orthobiologics Market By Application
184.108.40.206 Italy Orthobiologics Market By End User
220.127.116.11 Spain Orthobiologics Market By Product Type
18.104.22.168 Spain Orthobiologics Market By Application
22.214.171.124 Spain Orthobiologics Market By End User
11.3.10 The Netherlands
126.96.36.199 Netherlands Orthobiologics Market By Product Type
188.8.131.52 Netherlands Orthobiologics Market By Application
184.108.40.206 Netherlands Orthobiologics Market By End User
11.3.11 Rest of Europe
220.127.116.11 Rest of Europe Orthobiologics Market By Product Type
18.104.22.168 Rest of Europe Orthobiologics Market By Application
22.214.171.124 Rest of Europe Orthobiologics Market By End User
11.4.1 Asia Pacific Orthobiologics Market By Country
11.4.2 Asia Pacific Orthobiologics Market By Product Type
11.4.3 Asia Pacific Orthobiologics Market By Application
11.4.4 Asia-Pacific Orthobiologics Market By End User
126.96.36.199 Japan Orthobiologics Market By Product Type
188.8.131.52 Japan Orthobiologics Market By Application
184.108.40.206 Japan Orthobiologics Market By End User
11.4.6 South Korea
220.127.116.11 South Korea Orthobiologics Market By Product Type
18.104.22.168 South Korea Orthobiologics Market By Application
22.214.171.124 South Korea Orthobiologics Market By End User
126.96.36.199 China Orthobiologics Market By Product Type
188.8.131.52 China Orthobiologics Market By Application
184.108.40.206 China Orthobiologics Market By End User
220.127.116.11 India Orthobiologics Market By Product Type
18.104.22.168 India Orthobiologics Market By Application
22.214.171.124 India Orthobiologics Market By End User
126.96.36.199 Australia Orthobiologics Market By Product Type
188.8.131.52 Australia Orthobiologics Market By Application
184.108.40.206 Australia Orthobiologics Market By End User
11.4.10 Rest of Asia-Pacific
220.127.116.11 APAC Orthobiologics Market By Product Type
18.104.22.168 APAC Orthobiologics Market By Application
22.214.171.124 APAC Orthobiologics Market By End User
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Orthobiologics Market By Country
11.5.2 The Middle East & Africa Orthobiologics Market By Product Type
11.5.3 The Middle East & Africa Orthobiologics Market By Application
11.5.4 The Middle East & Africa Orthobiologics Market By End User
126.96.36.199 Israel Orthobiologics Market By Product Type
188.8.131.52 Israel Orthobiologics Market By Application
184.108.40.206 Israel Orthobiologics Market By End User
220.127.116.11 UAE Orthobiologics Market By Product Type
18.104.22.168 UAE Orthobiologics Market By Application
22.214.171.124 UAE Orthobiologics Market By End User
11.5.7 South Africa
126.96.36.199 South Africa Orthobiologics Market By Product Type
188.8.131.52 South Africa Orthobiologics Market By Application
184.108.40.206 South Africa Orthobiologics Market By End User
11.5.8 Rest of Middle East & Africa
220.127.116.11 Rest of Middle East & Asia Orthobiologics Market By Product Type
18.104.22.168 Rest of Middle East & Asia Orthobiologics Market By Application
22.214.171.124 Rest of Middle East & Africa Orthobiologics Market By End User
11.6 Latin America
11.6.1 Latin America Orthobiologics Market By Country
11.6.2 Latin America Orthobiologics Market By Product Type
11.6.3 Latin America Orthobiologics Market By Application
11.6.4 Latin America Orthobiologics Market By End User
126.96.36.199 Brazil Orthobiologics Market By Product Type
188.8.131.52 Brazil Africa Orthobiologics Market By Application
184.108.40.206 Brazil Orthobiologics Market By End User
220.127.116.11 Argentina Orthobiologics Market By Product Type
18.104.22.168 Argentina Orthobiologics Market By Application
22.214.171.124 Argentina Orthobiologics Market By End User
11.6.7 Rest of Latin America
126.96.36.199 Rest of Latin America Orthobiologics Market By Product Type
188.8.131.52 Rest of Latin America Orthobiologics Market By Application
184.108.40.206 Rest of Latin America Orthobiologics Market By End User
12. Company profile
12.1 Medtronic PLC
12.1.1 Market Overview
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Exactech Inc
12.2.1 Market Overview
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Synthes Inc
12.3.1 Market Overview
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Stryker Corporation
12.4.1 Market Overview
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Zimmer Biomet
12.5.1 Market Overview
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Smith & Nephew PLC
12.6.1 Market Overview
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Tornier Inc
12.7.1 Market Overview
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 DePuy Synthes Inc
12.8.1 Market Overview
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 RTI Surgical Inc
12.9.1 Market Overview
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Bioventus LLC
12.10.1 Market Overview
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
14. Used Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Softgel Capsule Market Size was valued at USD 7.21 billion in 2022 and is expected to reach USD 12.97 billion by 2030, and grow at a CAGR of 7.6% over the forecast period 2023-2030.
The Digestive Health Market size was USD 49.46 Billion in 2022 and is expected to Reach USD 94.41 Billion by 2030 and grow at a CAGR of 8.5% over the forecast period of 2023-2030.
The Toxoid Vaccine market size was worth US$ 5.61 billion in 2022 and is estimated to reach US$ 8.22 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2023-2030.
The Biomarkers Market, size was estimated USD 66.8 billion in 2022 and is expected to reach USD182.6 billion by 2030 at a CAGR of 13.4% during the forecast period of 2023-2030.
The Dental Hygiene Devices Market Size was valued at USD 4.51 billion in 2022 and is expected to reach USD 6.72 billion by 2030, and grow at a CAGR of 5.1% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone